Medtecs International Corporation Ltd DRC (9103) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.027x

Based on the latest financial reports, Medtecs International Corporation Ltd DRC (9103) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$2.80 Million ≈ $88.32K USD) by net assets (NT$102.11 Million ≈ $3.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 9103 equity to assets ratio to measure how much of total assets are equity-financed.

Medtecs International Corporation Ltd DRC - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Medtecs International Corporation Ltd DRC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 9103 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Medtecs International Corporation Ltd DRC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medtecs International Corporation Ltd DRC ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Pyxis Oncology Inc
NASDAQ:PYXS
-0.193x
Aura Energy Ltd
AU:AEE
-0.078x
Peace Acquisition Corp Ordinary Shares
NASDAQ:PECE
3.620x
Celxpert Energy
TWO:3323
0.025x
Valuence Merger Corp I
NASDAQ:VMCA
-0.014x
IBI Lion SOCIMI S.A.
MC:YIBI
0.006x
True North Commercial Real Estate Investment Trust
TO:TNT-UN
0.042x
Ultralife Corporation
NASDAQ:ULBI
0.017x

Annual Cash Flow Conversion Efficiency for Medtecs International Corporation Ltd DRC (2009–2025)

The table below shows the annual cash flow conversion efficiency of Medtecs International Corporation Ltd DRC from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Medtecs International Corporation Ltd DR (9103) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$102.11 Million
≈ $3.22 Million
NT$-1.88 Million
≈ $-59.09K
-0.018x -730.28%
2024-12-31 NT$107.05 Million
≈ $3.37 Million
NT$312.00K
≈ $9.83K
0.003x +105.29%
2023-12-31 NT$130.31 Million
≈ $4.11 Million
NT$-7.18 Million
≈ $-226.37K
-0.055x -107.22%
2022-12-31 NT$152.31 Million
≈ $4.80 Million
NT$-4.05 Million
≈ $-127.69K
-0.027x -116.61%
2021-12-31 NT$187.91 Million
≈ $5.92 Million
NT$30.10 Million
≈ $948.44K
0.160x -69.33%
2020-12-31 NT$194.49 Million
≈ $6.13 Million
NT$101.59 Million
≈ $3.20 Million
0.522x +672.04%
2019-12-31 NT$64.59 Million
≈ $2.03 Million
NT$4.37 Million
≈ $137.68K
0.068x -23.80%
2018-12-31 NT$63.35 Million
≈ $2.00 Million
NT$5.62 Million
≈ $177.22K
0.089x +136.05%
2017-12-31 NT$62.92 Million
≈ $1.98 Million
NT$2.37 Million
≈ $74.57K
0.038x -50.48%
2016-12-31 NT$61.86 Million
≈ $1.95 Million
NT$4.70 Million
≈ $148.04K
0.076x -33.63%
2015-12-31 NT$60.46 Million
≈ $1.90 Million
NT$6.92 Million
≈ $218.02K
0.114x -27.82%
2014-12-31 NT$56.24 Million
≈ $1.77 Million
NT$8.92 Million
≈ $280.97K
0.159x +72.61%
2013-12-31 NT$56.53 Million
≈ $1.78 Million
NT$5.19 Million
≈ $163.61K
0.092x +58.69%
2012-12-31 NT$56.56 Million
≈ $1.78 Million
NT$3.27 Million
≈ $103.15K
0.058x -62.73%
2011-12-31 NT$54.60 Million
≈ $1.72 Million
NT$8.48 Million
≈ $267.23K
0.155x +11.36%
2010-12-31 NT$53.45 Million
≈ $1.68 Million
NT$7.46 Million
≈ $234.90K
0.139x -40.33%
2009-12-31 NT$50.65 Million
≈ $1.60 Million
NT$11.84 Million
≈ $373.06K
0.234x --

About Medtecs International Corporation Ltd DRC

TW:9103 Taiwan Medical Instruments & Supplies
Market Cap
$86.53 Million
NT$2.75 Billion TWD
Market Cap Rank
#19632 Global
#1117 in Taiwan
Share Price
NT$5.04
Change (1 day)
-0.40%
52-Week Range
NT$4.36 - NT$6.39
All Time High
NT$71.50
About

Medtecs International Corporation Limited, an integrated healthcare services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups. It operates through Manufacturing, Hospital, and Distribution and Others segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients'… Read more